SCHEMBL8973004

SCHEMBL8973004

Cc1cnc2c(Br)c(NC3=NCCN3)ccc2n1.Cc1cnc2cc([N+](=O)[O-])ccc2n1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 12/20 0.73
ADRA2B P18089 12/20 0.73
ADRA2C P18825 12/20 0.73
ADRA1D P25100 11/20 0.73
ADRA1B P35368 9/20 0.53
ADRA1A P35348 8/20 0.53
MAPT P10636 3/20 0.53
KDM4E B2RXH2 1/20 0.53
NR1I2 O75469 1/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
HTR1A P08908 1/20 0.53
CYP2D6 P10635 1/20 0.53
HPGD P15428 1/20 0.53
ALOX15 P16050 1/20 0.53
MAPK1 P28482 1/20 0.53
BLM P54132 1/20 0.53
HSD17B10 Q99714 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7031798 0.85 ADRA2A (1.00) ADRA2AADRA2BADRA2CADRA1DADRA1B
SCHEMBL253111 0.79 ADRA2A (0.82) ADRA2AADRA2BADRA2CADRA1DADRA1B
SCHEMBL7784448 0.74 ADRA2C (0.70) ADRA2AADRA2BADRA2CADRA1DADRA1B
SCHEMBL1551650 0.74 SMN1; SMN2 (0.50) MAPTALDH1A1LMNACYP1A2CYP3A4
SCHEMBL251823 0.73 ADRA2A (0.75) ADRA2AADRA2BADRA2CADRA1DADRA1B
SCHEMBL5827504 0.72 HTR1D (0.66) ADRA2AADRA2BADRA2CADRA1DADRA1B
SCHEMBL7032974 0.72 ADRA2A (0.73) ADRA2AADRA2BADRA2CADRA1DADRA1B
Brimonidine SCHEMBL29374525 0.71 ADRA2A (1.00) ADRA2AADRA2BADRA2CADRA1DADRA1B
Brimonidine SCHEMBL20511531 0.71 ADRA2A (1.00) ADRA2AADRA2BADRA2CADRA1DADRA1B
Brimonidine SCHEMBL24670 0.71 ADRA2A (1.00) ADRA2AADRA2BADRA2CADRA1DADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5587376-A ANTIISCHEMIC AGENTS, DECONGESTANTS ALLERGAN (US) 1996-12-24 US disclosed
EP-0723447-A1 METHODS FOR USING (2-IMIDAZOLIN-2-YLAMINO) QUINOXALINE DERIVATIVES Allergan (US) 1996-07-31 EP disclosed
WO-1995010280-A1 METHODS FOR USING (2-IMIDAZOLIN-2-YLAMINO) QUINOXALINE DERIVATIVES ALLERGAN (US) 1995-04-20 WO disclosed